Monkey on your back

VTEConsultant

Share with a colleague

EXPERT PERSPECTIVES

Informative Discussions

The following Webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the major barriers to implementing appropriate VTE prophylaxis and solutions to overcome them. A discussion concerning the need to integrate evidence-based guidelines into policy and local clinical practice is also offered.

The Magnitude of Thromboembolic Disease and the
Need for Thromboprophylaxis.


Alexander G. G. Turpie
Professor of Medicine
McMaster University
Hamilton, Ontario
Canada



The Risk of VTE in Total Joint Replacement Patients.


Joseph A. Caprini, MD, MS, FACS, RVT
Louis W. Biegler Professor of Surgery and Bioengineering
Robert R. McCormick School of Engineering and Applied Sciences
Division of Vascular Surgery, NorthShore University Health System, Evanston, IL
Northwestern University Feinberg School of Medicine, Chicago, IL



The Importance of Integrating National, Evidence-Based Guideline Statements into Policy and Local Clinical Protocols.


Richard J. Friedman, MD, FRCSC
Clinical Professor of Orthopaedic Surgery
Medical University of South Carolina



Barriers to VTE Prophylaxis


Geno J. Merli, MD, FACP
Professor of Medicine
Director of Jefferson Center for Vascular Disease
Jefferson Medical College
Senior Vice President and Chief Medical Officer
Thomas Jefferson University Hospital



FACT:

Despite current anticoagulant prophylaxis, venous thromboembolism (VTE) still happens:

  • 12% to 24% of patients undergoing hip replacement surgery developed total deep vein thrombosis (DVT)* despite anticoagulant prophylaxis13-15
  • 25% to 45% of patients undergoing knee replacement surgery developed total DVT* despite anticoagulant prophylaxis16,17

*Total DVT includes proximal and distal DVT as assessed by venography.